UniProtKB/Swiss-Prot P08100: Variant p.Gly51Ala

Rhodopsin
Gene: RHO
Feedback?

Variant information Variant position:

51 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:

LB/B The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Glycine (G) to Alanine (A) at position 51 (G51A, p.Gly51Ala). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:

Change from glycine (G) to small size and hydrophobic (A) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:

0 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page
Other resources:

Links to websites of interest for the variant.

Variant rs149079952 [ dbSNP | Ensembl ]

Sequence information Variant position:

51 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:

348 The length of the canonical sequence.
Location on the sequence:

LAEPWQFSMLAAYMFLLIVL G FPINFLTLYVTVQHKKLRTP The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         LAEPWQFSMLAAYMFLLIVLGFPINFLTLYVTVQHKKLRTP

                              LAEPWQFSMLAAYMFLLIVLGFPINFLTLYVTVQHKKLRTP

Mouse                         LAEPWQFSMLAAYMFLLIVLGFPINFLTLYVTVQHKKLRTP

Rat                           LAEPWQFSMLAAYMFLLIVLGFPINFLTLYVTVQHKKLRTP

Pig                           LAEPWQFSMLAAYMFMLIVLGFPINFLTLYVTVQHKKLRTP

Bovine                        LAEPWQFSMLAAYMFLLIMLGFPINFLTLYVTVQHKKLRTP

Rabbit                        LAEPWQFSMLAAYMFLLIVLGFPINFLTLYVTVQHKKLRTP

Sheep                         LAEPWQFSMLAAYMFLLIVLGFPINFLTLYVTVQHKKLRTP

Cat                           LAEPWQFSMLAAYMFLLIVLGFPINFLTLYVTVQHKKLRTP

Chicken                       LAEPWKFSALAAYMFMLILLGFPVNFLTLYVTIQHKKLRTP

Xenopus laevis                LAEPWQYSALAAYMFLLILLGLPINFMTLFVTIQHKKLRTP

Zebrafish                     LVAPWAYGLLAAYMFFLIITGFPVNFLTLYVTIEHKKLRTP

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	1 – 348	Rhodopsin
Transmembrane	37 – 61	Helical; Name=1
Helix	35 – 64

Literature citations
Identification of novel rhodopsin mutations responsible for retinitis pigmentosa: implications for the structure and function of rhodopsin.
Macke J.P.; Davenport C.M.; Jacobson S.G.; Hennessey J.C.; Gonzalez-Fernandez F.; Conway B.P.; Heckenlively J.; Palmer R.; Maumenee I.H.; Sieving P.; Gouras P.; Good W.; Nathans J.;
Am. J. Hum. Genet. 53:80-89(1993)
Cited for: VARIANTS RP4 ARG-106; GLY-135; SER-140; GLU-188 AND ARG-211; VARIANTS ALA-51; ILE-104 AND MET-209;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.